-
Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group
Spanjaart, A. M., Ljungman, P., Tridello, G., Schwartz, J., Martinez-Cibrián, N., Barba, P., Kwon, M., Lopez-Corral, L., Martinez-Lopez, J., Ferra, C., di Blasi, R., Ghesquieres, H., Mutsaers, P., Calkoen, F., Jak, M., van Doesum, J., Vermaat, J. S. P., van der Poel, M., Maertens, J. & Gambella, M. & 22 others, , Sept 2024, In: Leukemia. 38, 9, p. 1985-1991 7 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Feasibility of CD19 CAR T-cell therapy in patients with cardiac lymphoma
Kuipers, M. T., Spanjaart, A. M., Bonifazi, F., diBlasi, R., Zinzani, P. L., Thieblemont, C., Baudet, M., Biemond, B. J., Kok, W. E. M. & Kersten, M. J., 2024, In: Leukemia & lymphoma. 65, 3, p. 399-402 4 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic
-
Health-related quality of life dynamics: modeling insights from immunotherapy
Hasgul, Z., Spanjaart, A., Javed, S., Akhavan, A., Kersten, M. J. & Jalali, M. S., 2024, (E-pub ahead of print) In: Quality of life research.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
